Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 63 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5P30CA006927-49
Transgenic Mouse
National Institutes of Health
Grant: 5R01CA218802-04
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
National Institutes of Health
Grant: 5P50DE030707-02
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
National Institutes of Health
Grant: 4R37CA222294-06
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
NCI NIH HHS
Grant: P30 CA023100
FWCI
5.47
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals